Potential Relationship Between YTHDF3 and CFTR in Myocardial Ischemia-Reperfusion Injury

Baoxin Tang1, Chenying Zhu2, Heqing Wang3

  • 1Department of Cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

Insights

Myocardial ischemia-reperfusion injury (MIRI) involves YTHDF3 aggravating damage, while CFTR offers protection. This study reveals their interaction, suggesting therapeutic potential for MIRI.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Genetics and Genomics

Background:

  • Myocardial ischemia-reperfusion injury (MIRI) worsens outcomes after myocardial infarction and reperfusion therapy.
  • Understanding MIRI's regulatory targets is crucial for improving patient prognosis.

Purpose of the Study:

  • To identify key regulatory genes and mechanisms involved in myocardial ischemia-reperfusion injury.
  • To investigate the roles of YTHDF3 and CFTR in MIRI and their interaction.

Main Methods:

  • Analysis of gene expression datasets (GSE123342, GSE6381) to identify differentially expressed genes and hub genes.
  • Construction of protein-protein interaction, transcription factor regulatory, and weighted gene co-expression networks.
  • In vitro (AC16 cells, OGD/OGR model) and in vivo (rat I/R model) experiments to assess YTHDF3 and CFTR functions.

Main Results:

  • CFTR was significantly upregulated in MIRI datasets, while YTHDF3 expression decreased in vitro under injury conditions.
  • YTHDF3 overexpression exacerbated MIRI in vitro and in vivo, increasing cell injury and infarct size.
  • CFTR overexpression attenuated YTHDF3-induced injury, suggesting a protective role, and CFTR knockdown worsened injury.

Conclusions:

  • YTHDF3 is implicated in exacerbating myocardial ischemia-reperfusion injury.
  • CFTR plays a protective role against MIRI, potentially counteracting YTHDF3's detrimental effects.
  • The YTHDF3-CFTR axis presents a potential therapeutic target for mitigating MIRI.